“Molecular Docking, Bioactivity, Adme, Toxicity Risks, and Quantum Mechanical Parameters of Some 1,2-Dihydroquinoline Derivatives Were Calculated Theoretically for Investigation of Its Use As a Pharmaceutical Active Ingredient in the Treatment of Multiple Sclerosis (MS)”. 2024. Prospects in Pharmaceutical Sciences 22 (4): 168-87. https://doi.org/10.56782/pps.261.